|
Article Excerpt
CALGARY -- Fero Industries, Inc. (OTCBB: FROI) (the "Company") is pleased to announce to the appointment of Robert C. Moellering, Jr., M.D. as Chairman of the Scientific Advisory Board of Pyro Pharmaceuticals, Inc. As previously announced, the Company has executed a share exchange agreement with Pyro Pharmaceuticals, Inc. for the acquisition of Pyro through an exchange of Pyro's capital stock for shares of the Company's common stock, with Fero remaining as the parent entity and Pyro as a subsidiary. The acquisition of Pyro is expected to close by November 30, 2009. The closing is subject to satisfaction of certain conditions, including the requisite approval of Pyro's shareholders and procurement of financing.
Robert C. Moellering, Jr., M.D., is...
|
|
More articles from Business Wire
Lothar Koob Joins EDGE Medical Devices Board of Directors., November 10, 2009
IFF to Present at the Morgan Stanley Global Consumer and Retail Confer..., November 10, 2009
CyberOptics Introduces Next-Generation Automated Optical Inspection Sy..., November 10, 2009
American Apparel Reports Third Quarter 2009 Financial Results.(Financi..., November 10, 2009
Spokn Perfects Internet Telephony., November 10, 2009
Looking for additional articles?
Search our database of over 3 million articles.
Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication
name or publication date.
About Goliath
Whether you're looking for sales prospects, competitive information, company
analysis or best practices in managing your organization,
Goliath can help you meet your business needs.
Our extensive business information databases empower business
professionals with both the breadth and depth of credible,
authoritative information they need to support their business
goals. Whether it be strategic planning, sales prospecting,
company research or defining management best practices -
Goliath is your leading source for accurate information.
|
|
